Unknown

Dataset Information

0

Simvastatin reduces venous stenosis formation in a murine hemodialysis vascular access model.


ABSTRACT: Venous neointimal hyperplasia (VNH) is responsible for hemodialysis vascular access malfunction. Here we tested whether VNH formation occurs, in part, due to vascular endothelial growth factor-A (VEGF-A) and matrix metalloproteinase (MMP)-9 gene expression causing adventitial fibroblast transdifferentiation to myofibroblasts (?-SMA-positive cells). These cells have increased proliferative and migratory capacity leading to VNH formation. Simvastatin was used to decrease VEGF-A and MMP-9 gene expression in our murine arteriovenous fistula model created by connecting the right carotid artery to the ipsilateral jugular vein. Compared to fistulae of vehicle-treated mice, the fistulae of simvastatin-treated mice had the expected decrease in VEGF-A and MMP-9 but also showed a significant reduction in MMP-2 expression with a significant decrease in VNH and a significant increase in the mean lumen vessel area. There was an increase in terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) staining, and decreases in ?-SMA density, cell proliferation, and HIF-1? and hypoxyprobe staining. This latter result prompted us to determine the effect of simvastatin on fibroblasts subjected to hypoxia in vitro. Simvastatin-treated fibroblasts had a significant decrease in myofibroblast production along with decreased cellular proliferation, migration, and MMP-9 activity but increased caspase 3 activity suggesting increased apoptosis. Thus, simvastatin results in a significant reduction in VNH, with increase in mean lumen vessel area by decreasing VEGF-A/MMP-9 pathway activity.

SUBMITTER: Janardhanan R 

PROVIDER: S-EPMC3731558 | biostudies-literature | 2013 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Simvastatin reduces venous stenosis formation in a murine hemodialysis vascular access model.

Janardhanan Rajiv R   Yang Binxia B   Vohra Pawan P   Roy Bhaskar B   Withers Sarah S   Bhattacharya Santanu S   Mandrekar Jaywant J   Kong Hyunjoon H   Leof Edward B EB   Mukhopadhyay Debabrata D   Misra Sanjay S  

Kidney international 20130501 2


Venous neointimal hyperplasia (VNH) is responsible for hemodialysis vascular access malfunction. Here we tested whether VNH formation occurs, in part, due to vascular endothelial growth factor-A (VEGF-A) and matrix metalloproteinase (MMP)-9 gene expression causing adventitial fibroblast transdifferentiation to myofibroblasts (α-SMA-positive cells). These cells have increased proliferative and migratory capacity leading to VNH formation. Simvastatin was used to decrease VEGF-A and MMP-9 gene expr  ...[more]

Similar Datasets

| S-EPMC8986037 | biostudies-literature
| S-EPMC6708782 | biostudies-literature
| S-EPMC5438785 | biostudies-literature
| S-EPMC3844094 | biostudies-literature
| S-EPMC3986087 | biostudies-literature
| S-EPMC4017945 | biostudies-literature
| S-EPMC4548543 | biostudies-literature
| S-EPMC4734360 | biostudies-literature
| S-EPMC3582201 | biostudies-literature
| S-EPMC4317740 | biostudies-literature